Skip to main content
Skip to section navigation
Skip to footer
About Us
Company Overview
Management
Board of Directors
Pipeline
Pipeline Overview
Paxalisib
PD-L1 Protein Degrader
SETDB1 Inhibitor
EVT801
Clinical Trials
Posters & Publications
Technology
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Investors
Investors Overview
News & Events
Company Info
Financial Results
Stock Data
SEC Filings
Governance
ASX Delisting
Contact Us
In The News
Media Center
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Year
All Years
2026
2025
2024
2023
2022
2021
2020
Dec 9, 2022
SMH: ‘Waiting for your child to die is not an option’
Dec 8, 2022
Kazia Therapeutics’ upcoming top-line data for EVT801 expected to be a share price catalyst: Edison Investment Research
Dec 5, 2022
Kazia Therapeutics talks positive pre-clinical data for EVT801
Dec 1, 2022
ASX opens to 7-month high after Powells positive news: Aus shares up 0.8%
Dec 1, 2022
Almost all sectors higher: Aus shares close up 1%
Nov 30, 2022
Kazia Therapeutics welcomes publication of positive pre-clinical data for EVT801 in peer-reviewed cancer research journal
Nov 1, 2022
ASX increases slightly ahead of today's interest rate rise: Aus shares 0.3% higher at noon
Oct 28, 2022
Kazia Therapeutics’ (ASX:KZA) paxalisib shows positive signals against preclinical melanoma models
Oct 28, 2022
Stocks of the Hour: Kazia Therapeutics, Green Technology Metals, Winsome Resources
Oct 28, 2022
US tech earnings weighing down Aus tech sector: ASX falls 0.62% at noon
rss_feed
RSS
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Next Page
arrow_forward
Select a page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8